Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1990 2
1992 2
1993 2
1995 1
1996 1
1997 2
1998 2
1999 2
2001 2
2002 4
2003 2
2004 2
2005 2
2006 5
2007 6
2008 7
2009 7
2010 4
2011 3
2012 10
2013 3
2014 5
2015 5
2016 7
2017 7
2018 8
2019 3
2020 10
2021 5
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Berger F, Marce M, Delaloge S, Hardy-Bessard AC, Bachelot T, Bièche I, Pradines A, De La Motte Rouge T, Canon JL, André F, Arnould L, Clatot F, Lemonnier J, Marques S, Bidard FC; PADA-1 investigators. Berger F, et al. BMJ Open. 2022 Mar 3;12(3):e055821. doi: 10.1136/bmjopen-2021-055821. BMJ Open. 2022. PMID: 35241469 Free PMC article. Clinical Trial.
Intervention to Promote Communication About Goals of Care for Hospitalized Patients With Serious Illness: A Randomized Clinical Trial.
Curtis JR, Lee RY, Brumback LC, Kross EK, Downey L, Torrence J, LeDuc N, Mallon Andrews K, Im J, Heywood J, Brown CE, Sibley J, Lober WB, Cohen T, Weiner BJ, Khandelwal N, Abedini NC, Engelberg RA. Curtis JR, et al. Among authors: leduc n. JAMA. 2023 Jun 20;329(23):2028-2037. doi: 10.1001/jama.2023.8812. JAMA. 2023. PMID: 37210665 Free PMC article.
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.
Vilotte F, Antoine M, Bobin M, Latorzeff I, Supiot S, Richaud P, Thomas L, Leduc N, Guérif S, Iriondo-Alberdi J, de Crevoisier R, Sargos P. Vilotte F, et al. Among authors: leduc n. Front Oncol. 2017 Mar 9;7:34. doi: 10.3389/fonc.2017.00034. eCollection 2017. Front Oncol. 2017. PMID: 28337425 Free PMC article. Review.
Impact of Device Implant Depth After Left Atrial Appendage Occlusion.
Cepas-Guillén P, Flores-Umanzor E, Leduc N, Bajoras V, Perrin N, Farjat-Pasos J, McInerney A, Lafond A, Millán X, Zendjebil S, O'Hara G, Ibrahim R, de Backer O, Cruz-González I, Arzamendi D, Sanchis L, Garot P, Nielsen-Kudsk JE, Nombela-Franco L, Aminian A, Rodés-Cabau J, Freixa X. Cepas-Guillén P, et al. Among authors: leduc n. JACC Cardiovasc Interv. 2023 Sep 11;16(17):2139-2149. doi: 10.1016/j.jcin.2023.05.045. Epub 2023 Aug 9. JACC Cardiovasc Interv. 2023. PMID: 37565966
Light Signaling in Bud Outgrowth and Branching in Plants.
Leduc N, Roman H, Barbier F, Péron T, Huché-Thélier L, Lothier J, Demotes-Mainard S, Sakr S. Leduc N, et al. Plants (Basel). 2014 Apr 23;3(2):223-50. doi: 10.3390/plants3020223. Plants (Basel). 2014. PMID: 27135502 Free PMC article. Review.
International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean.
Joachim C, Almont T, Drame M, Contaret C, Vestris M, Najioullah F, Aline-Fardin A, Escarmant P, Leduc N, Grossat N, Promeyrat X, Bougas S, Papadopoulou E, Vinh-Hung V, Sylvestre E, Veronique-Baudin J. Joachim C, et al. Among authors: leduc n. Global Health. 2020 Mar 4;16(1):20. doi: 10.1186/s12992-020-00551-w. Global Health. 2020. PMID: 32131844 Free PMC article. Review.
Genetics in health care: an overview of current and emerging models.
Battista RN, Blancquaert I, Laberge AM, van Schendel N, Leduc N. Battista RN, et al. Among authors: leduc n. Public Health Genomics. 2012;15(1):34-45. doi: 10.1159/000328846. Epub 2011 Jul 2. Public Health Genomics. 2012. PMID: 21734357 Free article. Review.
In Regard to Gajjar et al.
Leduc N, Escarmant P, Vinh-Hung V, Joachim C, Véronique-Baudin J. Leduc N, et al. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1600-1601. doi: 10.1016/j.ijrobp.2018.08.044. Int J Radiat Oncol Biol Phys. 2018. PMID: 31014794 No abstract available.
119 results